Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma

HIGHLIGHTS

• who: Liqin Xu from the The University Hong Kong, Hong Kong SAR, China have published the research: Genomic and microbial factors affect the prognosis of anti-pd-1 immunotherapy in nasopharyngeal carcinoma, in the Journal: (JOURNAL)
• what: The authors characterized the gut microbiota in 50 RM-NPC patients that received anti-PD-1 treatment, and excluded 9 in the following analysis due to confounding effects from antibiotics.
• how: Statistical analyses were mainly performed in the program R version 3.4.3 with the following packages spearman correlation performed by cor Wilcoxon test performed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.